These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


346 related items for PubMed ID: 10870032

  • 1. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
    Colao A, Spiezia S, Di Somma C, Marzullo P, Cerbone G, Pivonello R, Faggiano A, Lombardi G.
    Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
    [Abstract] [Full Text] [Related]

  • 2. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
    Colao A, Marzullo P, Spiezia S, Ferone D, Giaccio A, Cerbone G, Pivonello R, Di Somma C, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
    [Abstract] [Full Text] [Related]

  • 3. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S, Corcoran C, Stanley T, Katznelson L, Klibanski A.
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [Abstract] [Full Text] [Related]

  • 5. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients.
    Colao A, Di Somma C, Spiezia S, Filippella M, Pivonello R, Lombardi G.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):88-94. PubMed ID: 12519835
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 8. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults.
    Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS.
    Eur J Endocrinol; 1999 Dec; 141(6):601-8. PubMed ID: 10601963
    [Abstract] [Full Text] [Related]

  • 9. Impaired cardiac performance in elderly patients with growth hormone deficiency.
    Colao A, Cuocolo A, Di Somma C, Cerbone G, Della Morte AM, Nicolai E, Lucci R, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3950-5. PubMed ID: 10566633
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [Abstract] [Full Text] [Related]

  • 11. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency.
    Colao A, Cerbone G, Pivonello R, Aimaretti G, Loche S, Di Somma C, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1277-82. PubMed ID: 10199767
    [Abstract] [Full Text] [Related]

  • 12. Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: impact of gonadal steroid and GH secretory changes on metabolic outcomes.
    Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samojlik E, Hintz RL, Veldhuis JD.
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3710-9. PubMed ID: 9360530
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
    Skjaerbaek C, Vahl N, Frystyk J, Hansen TB, Jørgensen JO, Hagen C, Christiansen JS, Orskov H.
    Eur J Endocrinol; 1997 Aug; 137(2):132-7. PubMed ID: 9272100
    [Abstract] [Full Text] [Related]

  • 16. Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults.
    Corneli G, Di Somma C, Prodam F, Bellone J, Bellone S, Gasco V, Baldelli R, Rovere S, Schneider HJ, Gargantini L, Gastaldi R, Ghizzoni L, Valle D, Salerno M, Colao A, Bona G, Ghigo E, Maghnie M, Aimaretti G.
    Eur J Endocrinol; 2007 Dec; 157(6):701-8. PubMed ID: 18057376
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of adult patients with growth hormone deficiency who underwent neurosurgery for functioning and non-functioning pituitary adenomas and craniopharyngiomas.
    Baldelli R, Bianchi A, Diacono F, Passeri M, Fusco A, Valle D, Poggi M, Terlini M, Toscano V, Tamburrano G, Pontecorvi A, Maira G, De Marinis L.
    J Endocrinol Invest; 2005 Feb; 28(2):157-61. PubMed ID: 15887862
    [Abstract] [Full Text] [Related]

  • 18. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
    Weinzimer SA, Homan SA, Ferry RJ, Moshang T.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 20. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Nov; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.